Author

Uta Dichristin

Observed name: U. Dichristin

Observed institutions: OLVG, Thrombosis Research Institute

OpenAlex ID: A5048938136

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

2020 · Carolyn S. P. Lam, Anna Giczewska, et al. · JAMA Cardiology · 85

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

2019 · Shinya Goto, Pantep Angchaisuksiri, et al. · Journal of the American Heart Association · 53

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

2025 · Faiez Zannad, Christopher M O'Connor, et al. · The Lancet · 51

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

2018 · Jitendra PS. Sawhney, Veerappa A. Kothiwale, et al. · Indian Heart Journal · 22

Works count: 4

Citation count: 211

H-index: 4

I10-index: 4